Myoelectric Robot-assisted Rehabilitation for the Upper Limb After Stroke (MyoReArm)

June 30, 2017 updated by: Andrea Turolla, IRCCS San Camillo, Venezia, Italy

A Pilot Study of Active, Robot-assisted Therapy for Shoulder Rehabilitation After Stroke, Using Myoelectric Signals

The aim of this study is to assess the clinical effectiveness of the RehaARM-robot and to determine the feasibility of including robotic therapy in daily rehabilitation programmes, after stroke. Additionally, we aim to investigate the acceptance of this intervention from patients and therapists. A total of 10 patients will be recruited in this study, all the patients will receive 1 hour of standard therapy together with 45 min of robot therapy every day. The robot therapy will last 45 minutes, for 15 consecutive days within a maximum period of four weeks. Additional 15 minutes are required for placing surface electrodes on the shoulder and patient preparation. The study will include passive and active shoulder training of four movements: Horizontal abduction/adduction, abduction/adduction, internal/external rotation and flexion/extension. The passive part lasts 10 minutes and the active part 35 minutes.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Anticipated)

10

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Linz, Austria, 4040
        • FerRobotics Compliant Robot Technology GmbH
      • Venice, Italy, 30126
        • IRCCS San Camillo Hospital Foundation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients suffering from stroke, ischemic and / or hemorrhagic
  • Stroke in the left hemisphere
  • Score between 1 and 3 in the upper-limb sub-item of the Italian version of the National Institute of Health Stroke Scale (IT-NIHSS) (Pezzella et al. 2009)
  • Score of the Functional Independence Measure (FIM) scale (Keith et al., 1987) less than 100 out of a total of 126. This scale is used as a reference to indicate the degree of autonomy in carrying out activities of daily living (ADLs)
  • Score of the upper-limb Fugl-Meyer scale (FMA) (Fugl-Meyer et al., 1975) less than 60. This scale measures the residual motor function of a person after stroke

Exclusion Criteria:

  • Non-stabilized fractures
  • Diagnosis of depression
  • Traumatic brain Injury
  • Pharmacologically uncontrolled epilepsy
  • Ideomotor apraxia
  • Neglect
  • Mini Mental State Examination (MMSE) score <20/30
  • Severe impairment of verbal comprehension, defined by a score in the Token Test (Tau points<58/78)
  • Patients participating in other rehabilitation treatments for the upper-limb (e.g. virtual reality treatment, motor imagery, etc)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: The RehaARM-Robot
Receive 45 min of robot-assisted therapy for the shoulder and 1 hour of daily standard rehabilitation therapy.
Robot therapy by using a 3-Degrees-Of-Freedom (3DOFs) robot to train the shoulder.
Other Names:
  • Robot-assisted therapy for the shoulder
Standard therapy of stroke rehabilitation including speech, physical, occupational therapies and group activities.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl-Meyer Assessment scale - Upper Extremity (FMA-UE)
Time Frame: 3 weeks (15 sessions)
Motor function of the upper limb is measured by means of the Upper Extremity Motor Assessment of the Fugl-Meyer Assessment Scale.
3 weeks (15 sessions)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Independence Measure (FIM)
Time Frame: 3 weeks (15 sessions)
FIM is an 18-item scale that assesses patient's disability and medical rehabilitation functional outcome (A total of 126 points).
3 weeks (15 sessions)
Reaching Performance Scale (RPS)
Time Frame: 3 weeks (15 sessions)
It assesses the ability of subjects to reach an object (a cone). The cone is placed at a 4-cm distance and after at a 30-cm distance from the subject. The subject is asked to reach and grab the cone if possible. The observer evaluates the quality of reaching instead of the grip strength ( A total of 36 points).
3 weeks (15 sessions)
Modified Ashworth Scale (MAS) of five muscles
Time Frame: 3 weeks (15 sessions)
Spasticity is measured using the MAS of five muscles: Pectoralis major, biceps, wrist flexors, flexor digitorum superficialis, flexor digitorum profundus (Total of 20 points).
3 weeks (15 sessions)
Nine Hole Pegboard Test (NHPT)
Time Frame: 3 weeks (15 sessions)
It measures the dexterity of the hand. Patient should insert 9 pins in the board. There are 9 pins. The number of pins inserted in 50 min are registered or if the patient inserted 9 pins, then the time is registered.
3 weeks (15 sessions)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Shoulder active range of movement (ROM-S)
Time Frame: 3 weeks (15 sessions)
Active range improvement for shoulder abduction and flexion are measured using the Tyromotion Pablo System.
3 weeks (15 sessions)
• Average amount of active task repetitions of a sequence of motor tasks using the robot during a 1-hour therapy treatment.
Time Frame: 3 weeks (15 sessions)
A higher number of repetitions is a paramount for neuroplasticity. The ability of subjects to execute a larger of number of motor task repetitions with the robot after the treatment is measured.
3 weeks (15 sessions)
• Smoothness of the torque (i.e. Number of peaks of the torque, [n]) for a sequence of motor tasks using the robot during a 1-hour therapy treatment .
Time Frame: 3 weeks (15 sessions)
Smoothness is a measure of human movement coordination. Improvement of smoothness after the treatment is measured.
3 weeks (15 sessions)
• Average magnitude of the muscle activation during the active phase normalized by duration of the active phase (magnitude/time) for a sequence of motor tasks using the robot during a 1-hour therapy treatment.
Time Frame: 3 weeks (15 sessions)
3 weeks (15 sessions)
• Average similarity between the muscle (synergy) modules of the paretic arm and the muscle modules of the right arm of healthy subjects for a standard sequence of motor tasks using the robot during a 1-hour therapy treatment
Time Frame: 3 weeks (15 sessions)
3 weeks (15 sessions)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrea Turolla, MSc, IRCCS San Camillo Hospital Foundation, Venice (Italy)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

April 1, 2016

Study Completion (Actual)

April 1, 2016

Study Registration Dates

First Submitted

December 11, 2014

First Submitted That Met QC Criteria

December 16, 2014

First Posted (Estimate)

December 22, 2014

Study Record Updates

Last Update Posted (Actual)

July 2, 2017

Last Update Submitted That Met QC Criteria

June 30, 2017

Last Verified

June 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on The RehaARM-Robot

3
Subscribe